Health Problems
Only Lyme disease vaccine in development goes to Phase 3 trials
The participants will get three doses of the vaccine, called VLA15, or a placebo, followed by a booster dose. “With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” Annaliesa Anderson, senior vice president and Read more…